Rapid or significant weight loss, a common effect of GLP-1 medications, can disrupt the hair growth cycle and contribute to increased shedding and hair thinning
About this article Cite this article Hasanzad, M., Patrinos, G.P., Aghaei Meybodi, H.R
Retatrutide (GLP3) is a triple agonist adding glucagon for energy expenditure and fat burning, with phase 2/3 trials showing 2428.7% average weight loss over 4868 weekspotentially double semaglutides impact. What weight loss results have retatrutide shown in trials
Common Side Effects: Gastrointestinal issues like nausea, diarrhea, or constipation
Interpreting its relationship with cardiovascular risk is complex and depends on dietary and clinical context, so simplistic conclusions should be avoided